Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series
Open Access
- 23 March 2021
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 87 (2), 223-226
- https://doi.org/10.4103/ijdvl.ijdvl_455_18
Abstract
Psoriasis and hidradenitis suppurativa are inflammatory dermatoses that have been associated with arthritis, metabolic syndrome, obesity, and smoking. They share common pathogenic mechanisms such as elevated levels of several proinflammatory cytokines including tumor necrosis factor (TNF), interleukin-17A, and impaired Notch pathway. Thus, treatments for both diseases are sometimes overlapping. Biological therapy such as adalimumab is effective for patients with hidradenitis suppurativa and psoriasis. Adalimumab is a monoclonal antibody that binds to TNF and inhibits the cytokine interaction with the TNF receptors, thus inhibiting the inflammatory cascade. Currently, data are lacking on the treatment for co-occurrence of psoriasis and hidradenitis suppurativa. This case series describes three patients with a diagnosis of concomitant psoriasis and hidradenitis suppurativa. In these cases, after 12 weeks of treatment with adalimumab 40 mg every other week, the average Psoriasis Area Severity Index score reduced from 21.4 to 2.9 for psoriasis, Hidradenitis Suppurativa-Physician’s Global Assessment from 3.3 to 0.7, and pain Visual Analog Scale for hidradenitis suppurativa from 4.6 to 2. The results suggest that adalimumab is a treatment of choice for patients with concomitant hidradenitis suppurativa and psoriasis.Keywords
This publication has 9 references indexed in Scilit:
- British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017British Journal of Dermatology, 2017
- Interventions for Hidradenitis SuppurativaJAMA Dermatology, 2017
- Pathophysiology of hidradenitis suppurativa: An updateJournal of the American Academy of Dermatology, 2015
- Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): Experience of a tertiary medical centerJournal of the American Academy of Dermatology, 2015
- Biological therapy induces expression changes in Notch pathway in psoriasisArchiv für dermatologische Forschung, 2015
- Psoriasis and smoking: a systematic review and meta‐analysisBritish Journal of Dermatology, 2014
- Epidemiology and comorbidities of psoriasis patients in a national database in TaiwanJournal of Dermatological Science, 2011
- Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelaeBritish Journal of Dermatology, 2010
- Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glandsBritish Journal of Dermatology, 1990